Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2015

01.12.2015 | Clinical Case Report

Linezolid induced retinopathy

verfasst von: Dae Hyun Park, Tae Kwann Park, Young-Hoon Ohn, Jong Sook Park, Jee Ho Chang

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

While optic neuropathy is a well-known cause of visual disturbances in linezolid-treated patients, the possibility of linezolid-related retinopathy has not been investigated. Here, we report a case of retinopathy demonstrated by multifocal electroretinogram (mfERG) in a linezolid-treated patient.

Method and results

A 61-year-old man with extensively drug-resistant pulmonary tuberculosis treated with linezolid for 5 months presented with painless loss of vision in both eyes. The patient’s best corrected visual acuity was 20/50 in the right eye and 20/100 in the left eye. Fundus examination revealed mild disc edema, and color vision was defective in both eyes. Humphrey visual field tests showed a superotemporal field defect in the right eye and central and pericentral field defect in the left eye. Optical coherence tomography (OCT) revealed only mild optic disc swelling. In mfERG, central amplitudes were depressed in both eyes. Four months after the cessation of linezolid, visual acuity was restored to 20/20 right eye and 20/25 left eye. The color vision and visual field had improved. The OCT and mfEFG findings improved as well.

Conclusions

Although the clinical features were similar to linezolid-induced optic neuropathy, the mfERG findings suggest the possibility of a retinopathy through cone dysfunction.
Literatur
1.
Zurück zum Zitat Perry CM, Jarvis B (2001) Linezolid: a review of its use in the management of serious gram-positive infections. Drugs 61:525–551CrossRefPubMed Perry CM, Jarvis B (2001) Linezolid: a review of its use in the management of serious gram-positive infections. Drugs 61:525–551CrossRefPubMed
2.
Zurück zum Zitat Sotgiu G, Centis R, D’Ambrosio L, Alffenaar JW, Anger HA, Caminero JA, Castiglia P, De Lorenzo S, Ferrara G, Koh WJ, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, Zellweger JP, Zumla A, Migliori GB (2012) Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 40:1430–1442CrossRefPubMed Sotgiu G, Centis R, D’Ambrosio L, Alffenaar JW, Anger HA, Caminero JA, Castiglia P, De Lorenzo S, Ferrara G, Koh WJ, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, Zellweger JP, Zumla A, Migliori GB (2012) Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 40:1430–1442CrossRefPubMed
3.
Zurück zum Zitat Zhang L, Pang Y, Yu X, Wang Y, Gao M, Huang H, Zhao Y (2014) Linezolid in the treatment of extensively drug-resistant tuberculosis. Infection 42:705–711CrossRefPubMed Zhang L, Pang Y, Yu X, Wang Y, Gao M, Huang H, Zhao Y (2014) Linezolid in the treatment of extensively drug-resistant tuberculosis. Infection 42:705–711CrossRefPubMed
4.
Zurück zum Zitat Sotgiu G, Pontali E, Migliori GB (2015) Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios. Eur Respir J 45:25–29CrossRefPubMed Sotgiu G, Pontali E, Migliori GB (2015) Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios. Eur Respir J 45:25–29CrossRefPubMed
5.
Zurück zum Zitat Slatter JG, Adams LA, Bush EC, Chiba K, Daley-Yates PT, Feenstra KL, Koike S, Ozawa N, Peng GW, Sams JP, Schuette MR, Yamazaki S (2002) Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. Xenobiotica 32:907–924CrossRefPubMed Slatter JG, Adams LA, Bush EC, Chiba K, Daley-Yates PT, Feenstra KL, Koike S, Ozawa N, Peng GW, Sams JP, Schuette MR, Yamazaki S (2002) Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. Xenobiotica 32:907–924CrossRefPubMed
6.
Zurück zum Zitat Fung HB, Kirschenbaum HL, Ojofeitimi BO (2001) Linezolid: an oxazolidinone antimicrobial agent. Clin Ther 23:356–391CrossRefPubMed Fung HB, Kirschenbaum HL, Ojofeitimi BO (2001) Linezolid: an oxazolidinone antimicrobial agent. Clin Ther 23:356–391CrossRefPubMed
7.
Zurück zum Zitat Agrawal R, Addison P, Saihan Z, Pefkianaki M, Pavesio C (2015) Optic neuropathy secondary to linezolid for multidrug-resistant mycobacterial spinal tuberculosis. Ocul Immunol Inflamm 23:90–92CrossRefPubMed Agrawal R, Addison P, Saihan Z, Pefkianaki M, Pavesio C (2015) Optic neuropathy secondary to linezolid for multidrug-resistant mycobacterial spinal tuberculosis. Ocul Immunol Inflamm 23:90–92CrossRefPubMed
9.
Zurück zum Zitat Han J, Lee K, Rhiu S, Lee JB, Han SH (2013) Linezolid-associated optic neuropathy in a patient with drug-resistant tuberculosis. J Neuroophthalmol 33:316–318CrossRefPubMed Han J, Lee K, Rhiu S, Lee JB, Han SH (2013) Linezolid-associated optic neuropathy in a patient with drug-resistant tuberculosis. J Neuroophthalmol 33:316–318CrossRefPubMed
10.
Zurück zum Zitat Kiuchi K, Miyashiro M, Kitagawa C, Wada S (2009) Linezolid-associated optic neuropathy in a patient with ocular sarcoidosis. Jpn J Ophthalmol 53:420–424CrossRefPubMed Kiuchi K, Miyashiro M, Kitagawa C, Wada S (2009) Linezolid-associated optic neuropathy in a patient with ocular sarcoidosis. Jpn J Ophthalmol 53:420–424CrossRefPubMed
11.
Zurück zum Zitat Javaheri M, Khurana RN, O’Hearn TM, Lai MM, Sadun AA (2007) Linezolid-induced optic neuropathy: a mitochondrial disorder? Br J Ophthalmol 91:111–115PubMedCentralCrossRefPubMed Javaheri M, Khurana RN, O’Hearn TM, Lai MM, Sadun AA (2007) Linezolid-induced optic neuropathy: a mitochondrial disorder? Br J Ophthalmol 91:111–115PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Saijo T, Hayashi K, Yamada H, Wakakura M (2005) Linezolid-induced optic neuropathy. Am J Ophthalmol 139:1114–1116CrossRefPubMed Saijo T, Hayashi K, Yamada H, Wakakura M (2005) Linezolid-induced optic neuropathy. Am J Ophthalmol 139:1114–1116CrossRefPubMed
13.
Zurück zum Zitat McKinley SH, Foroozan R (2005) Optic neuropathy associated with linezolid treatment. J Neuroophthalmol 25:18–21CrossRefPubMed McKinley SH, Foroozan R (2005) Optic neuropathy associated with linezolid treatment. J Neuroophthalmol 25:18–21CrossRefPubMed
14.
Zurück zum Zitat Lee E, Burger S, Shah J, Melton C, Mullen M, Warren F, Press R (2003) Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis 37:1389–1391CrossRefPubMed Lee E, Burger S, Shah J, Melton C, Mullen M, Warren F, Press R (2003) Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis 37:1389–1391CrossRefPubMed
15.
Zurück zum Zitat Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Marmor MF, McCulloch DL, Palmowski-Wolfe AM, International Society For Clinical Electrophysiology of V (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124:1–13PubMedCentralCrossRefPubMed Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Marmor MF, McCulloch DL, Palmowski-Wolfe AM, International Society For Clinical Electrophysiology of V (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124:1–13PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Liu Y, Dinkin MJ, Loewenstein JI, Rizzo JF 3rd, Cestari DM (2008) Multifocal electroretinographic abnormalities in ethambutol-induced visual loss. J Neuroophthalmol 28:278–282CrossRefPubMed Liu Y, Dinkin MJ, Loewenstein JI, Rizzo JF 3rd, Cestari DM (2008) Multifocal electroretinographic abnormalities in ethambutol-induced visual loss. J Neuroophthalmol 28:278–282CrossRefPubMed
17.
Zurück zum Zitat Lai TY, Chan WM, Lam DS, Lim E (2005) Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy. Br J Ophthalmol 89:774–775PubMedCentralCrossRefPubMed Lai TY, Chan WM, Lam DS, Lim E (2005) Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy. Br J Ophthalmol 89:774–775PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Kuniyoshi K, Sakuramoto H, Nakao A, Takada S, Shimomura Y (2012) A case of bilateral, acquired, and acute dysfunction of short-wavelength-sensitive cone systems. Doc Ophthalmol 125:75–80CrossRefPubMed Kuniyoshi K, Sakuramoto H, Nakao A, Takada S, Shimomura Y (2012) A case of bilateral, acquired, and acute dysfunction of short-wavelength-sensitive cone systems. Doc Ophthalmol 125:75–80CrossRefPubMed
19.
Zurück zum Zitat Kim YG, Baek SH, Moon SW, Lee HK, Kim US (2011) Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy. Acta Ophthalmol 89:e52–e56CrossRefPubMed Kim YG, Baek SH, Moon SW, Lee HK, Kim US (2011) Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy. Acta Ophthalmol 89:e52–e56CrossRefPubMed
20.
Zurück zum Zitat Mantyjarvi MI (1990) Color vision defect as first symptom of progressive cone-rod dystrophy. J Clin Neuroophthalmol 10:266–270PubMed Mantyjarvi MI (1990) Color vision defect as first symptom of progressive cone-rod dystrophy. J Clin Neuroophthalmol 10:266–270PubMed
21.
Zurück zum Zitat Park SJ, Woo SJ, Park KH, Hwang JM, Chung H (2010) Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography. Investig Ophthalmol Vis Sci 51:3673–3679CrossRef Park SJ, Woo SJ, Park KH, Hwang JM, Chung H (2010) Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography. Investig Ophthalmol Vis Sci 51:3673–3679CrossRef
22.
Zurück zum Zitat Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y, International Society for Clinical Electrophysiology of V (2003) Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106:105–115CrossRefPubMed Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y, International Society for Clinical Electrophysiology of V (2003) Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106:105–115CrossRefPubMed
Metadaten
Titel
Linezolid induced retinopathy
verfasst von
Dae Hyun Park
Tae Kwann Park
Young-Hoon Ohn
Jong Sook Park
Jee Ho Chang
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2015
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-015-9518-6

Weitere Artikel der Ausgabe 3/2015

Documenta Ophthalmologica 3/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.